Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2012 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/29366 |
Resumo: | Centers for Disease Control and Prevention. Division of Global Migration and Quarantine. National Center for Emerging and Zoonotic Infectious Diseases. Atlanta, GA, USA. / Centers for Disease Control and Prevention. Division of Vector-Borne Diseases. National Center for Emerging and Zoonotic Infectious Diseases. Fort Collins, CO, USA. |
| id |
CRUZ_4f532bd0fdc58e85f94189beaee7c958 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/29366 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Gershman, Mark D.Staples, J. ErinBentsi-Enchill, Adwoa D.Breugelmans, J. GabrielleBrito, Glacus S.Camacho, Luiz Antonio BastosCotting, PascaleDomingo, CristinaDurbin, AnnaGascon, JoaquimGuenaneche, FouziaHayes, Edward B.Jelenik, ZsuzsannaKhromava, AlenaMartins, Reinaldo de MenezesWilson, Mario MasanaMassy, NathalieNasidi, AbdulsalamiNiedrig, MatthiasSherwat, AdamTsai, TheodoreVilella, AnnaWilson, Mary ElizabethKoh, Katrin S.2018-10-04T20:06:06Z2018-10-04T20:06:06Z2012GERSHMAN, M. D. et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, v. 30, n. 33, p. 5038-5058, jul. 2012.0264-410Xhttps://www.arca.fiocruz.br/handle/icict/2936610.1016/j.vaccine.2012.04.067engDoença viscerotrópicaVacina contra Febre AmarelaAcontecimento adversoImunizaçãoGuiaDefinição de casoViscerotropic diseaseYellow fever vaccineAdverse eventImmunizationGuidelineCase definitionVacina contra Febre AmarelaImunizaçãoGuiaViscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety datainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleCenters for Disease Control and Prevention. Division of Global Migration and Quarantine. National Center for Emerging and Zoonotic Infectious Diseases. Atlanta, GA, USA. / Centers for Disease Control and Prevention. Division of Vector-Borne Diseases. National Center for Emerging and Zoonotic Infectious Diseases. Fort Collins, CO, USA.World Health Organization. Department of Immunization, Vaccines, and Biologicals. Geneva, Switzerland.Institut Pasteur. Agence de Médecine Préventive. Paris, France.Hospital das Clinicas. Division of Clinical Immunology and Allergy. São Paulo, SP, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública. Rio de Janeiro, Brasil.Sanofipasteur. Global Pharmacovigilance & Epidemiology. Lyon, France. Robert Koch Institute. Berlin, Germany. / Sanofipasteur. Division of Safety Monitoring and Risk Management for Pediatric and Travel Vaccines. Lyon, France.Department of International Health. Center for Immunization Research. Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.Barcelona Centre for International Health Research. Barcelona, Espanha.National Centre of Epidemiology. International Traveller’s Health and Vaccination Centre. Budapest, Hungary.Sanofipasteur. Global Pharmacovigilance and Epidemiology Department. Toronto, Canada.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Ministry of Health. Epidemiology Direction. Buenos Aires Province, Argentina.Rouen University Hospital. Pharmacovigilance Regional Center of Upper-Normandy. Rouen, Cedex, France.Federal Ministry of Health. Federal Secretariat. Maitama, Abuja, Nigeria.National Institutes of Health. National Institute of Allergy and Infectious Diseases. Division of AIDS. Bethesda, USA.Novartis Vaccines. Cambridge, USA.Harvard School of Public Health. Department of Global Health and Population. Boston, USA.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/29366/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALBio-0013.pdfapplication/pdf852994https://www.arca.fiocruz.br/bitstream/icict/29366/2/Bio-0013.pdfd75cd666d8542005d0e6016ba864dbf2MD52TEXTBio-0013.pdf.txtBio-0013.pdf.txtExtracted texttext/plain98223https://www.arca.fiocruz.br/bitstream/icict/29366/3/Bio-0013.pdf.txt6498062d7bebfa356d19f1b99ebd7799MD53icict/293662018-10-05 02:00:58.678oai:www.arca.fiocruz.br:icict/29366Tk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-10-05T05:00:58Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| title |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| spellingShingle |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data Gershman, Mark D. Doença viscerotrópica Vacina contra Febre Amarela Acontecimento adverso Imunização Guia Definição de caso Viscerotropic disease Yellow fever vaccine Adverse event Immunization Guideline Case definition Vacina contra Febre Amarela Imunização Guia |
| title_short |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| title_full |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| title_fullStr |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| title_full_unstemmed |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| title_sort |
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| author |
Gershman, Mark D. |
| author_facet |
Gershman, Mark D. Staples, J. Erin Bentsi-Enchill, Adwoa D. Breugelmans, J. Gabrielle Brito, Glacus S. Camacho, Luiz Antonio Bastos Cotting, Pascale Domingo, Cristina Durbin, Anna Gascon, Joaquim Guenaneche, Fouzia Hayes, Edward B. Jelenik, Zsuzsanna Khromava, Alena Martins, Reinaldo de Menezes Wilson, Mario Masana Massy, Nathalie Nasidi, Abdulsalami Niedrig, Matthias Sherwat, Adam Tsai, Theodore Vilella, Anna Wilson, Mary Elizabeth Koh, Katrin S. |
| author_role |
author |
| author2 |
Staples, J. Erin Bentsi-Enchill, Adwoa D. Breugelmans, J. Gabrielle Brito, Glacus S. Camacho, Luiz Antonio Bastos Cotting, Pascale Domingo, Cristina Durbin, Anna Gascon, Joaquim Guenaneche, Fouzia Hayes, Edward B. Jelenik, Zsuzsanna Khromava, Alena Martins, Reinaldo de Menezes Wilson, Mario Masana Massy, Nathalie Nasidi, Abdulsalami Niedrig, Matthias Sherwat, Adam Tsai, Theodore Vilella, Anna Wilson, Mary Elizabeth Koh, Katrin S. |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Gershman, Mark D. Staples, J. Erin Bentsi-Enchill, Adwoa D. Breugelmans, J. Gabrielle Brito, Glacus S. Camacho, Luiz Antonio Bastos Cotting, Pascale Domingo, Cristina Durbin, Anna Gascon, Joaquim Guenaneche, Fouzia Hayes, Edward B. Jelenik, Zsuzsanna Khromava, Alena Martins, Reinaldo de Menezes Wilson, Mario Masana Massy, Nathalie Nasidi, Abdulsalami Niedrig, Matthias Sherwat, Adam Tsai, Theodore Vilella, Anna Wilson, Mary Elizabeth Koh, Katrin S. |
| dc.subject.other.pt_BR.fl_str_mv |
Doença viscerotrópica Vacina contra Febre Amarela Acontecimento adverso Imunização Guia Definição de caso |
| topic |
Doença viscerotrópica Vacina contra Febre Amarela Acontecimento adverso Imunização Guia Definição de caso Viscerotropic disease Yellow fever vaccine Adverse event Immunization Guideline Case definition Vacina contra Febre Amarela Imunização Guia |
| dc.subject.en.pt_BR.fl_str_mv |
Viscerotropic disease Yellow fever vaccine Adverse event Immunization Guideline Case definition |
| dc.subject.decs.pt_BR.fl_str_mv |
Vacina contra Febre Amarela Imunização Guia |
| description |
Centers for Disease Control and Prevention. Division of Global Migration and Quarantine. National Center for Emerging and Zoonotic Infectious Diseases. Atlanta, GA, USA. / Centers for Disease Control and Prevention. Division of Vector-Borne Diseases. National Center for Emerging and Zoonotic Infectious Diseases. Fort Collins, CO, USA. |
| publishDate |
2012 |
| dc.date.issued.fl_str_mv |
2012 |
| dc.date.accessioned.fl_str_mv |
2018-10-04T20:06:06Z |
| dc.date.available.fl_str_mv |
2018-10-04T20:06:06Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
GERSHMAN, M. D. et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, v. 30, n. 33, p. 5038-5058, jul. 2012. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/29366 |
| dc.identifier.issn.pt_BR.fl_str_mv |
0264-410X |
| dc.identifier.doi.none.fl_str_mv |
10.1016/j.vaccine.2012.04.067 |
| identifier_str_mv |
GERSHMAN, M. D. et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, v. 30, n. 33, p. 5038-5058, jul. 2012. 0264-410X 10.1016/j.vaccine.2012.04.067 |
| url |
https://www.arca.fiocruz.br/handle/icict/29366 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/29366/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/29366/2/Bio-0013.pdf https://www.arca.fiocruz.br/bitstream/icict/29366/3/Bio-0013.pdf.txt |
| bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 d75cd666d8542005d0e6016ba864dbf2 6498062d7bebfa356d19f1b99ebd7799 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813008876627296256 |